Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study

J. Bourhis , X. Sun , Y. Pointreau , C. Sire , C. Le Tourneau , Alexandre Coutte (1) , M-C. Kaminsky-Forrett , M. Alfonsi , P. Boisselier , L. Martin , J-P. Delord , F. Clatot , J. Miroir , F. Rolland , P. Crompton , S. Brienza , S. A. Szyldergemajn , C. Even , Y. Tao

1 CHIMERE - CHirurgie, IMagerie et REgénération tissulaire de l’extrémité céphalique - Caractérisation morphologique et fonctionnelle - UR UPJV 7516

Domaines: Sciences du Vivant [q-bio]

J. Bourhis, X. Sun, Y. Pointreau, C. Sire, C. Le Tourneau, et al.. Double-blind randomized phase II results comparing concurrent high-dose cisplatin chemorradiation (CRT) plus debio 1143 or placebo in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN): A GORTEC study. Annals of Oncology, 2019, 30 (5), pp.902. ⟨hal-03600473⟩